Also known as glucagon-like peptide-1 receptor agonists, the GLP-1 drug class includes prescription medications that are used to treat type 2 diabetes mellitus (T2DM) and obesity
Known to have microneedles made from biodegradable materials, the GLP-1 drug is said to be embedded inside the needles
Transparent Pricing Pay only for medications you need - no subscription or membership required Get it Fast Available on your first visit in our clinic or by 2-day shipping Quality Assured Each medication undergoes extensive quality checks US Manufactured Sourced from FDA registered pharmacies based in the USA The science behind Glucagon-Like Peptide-1
What are the concerns about compounded GLP-1 drugs
GIPR agonism could exert beneficial metabolic effects by enhancing glucose-stimulated insulin secretion, increasing postprandial adipose tissue blood flow and triglyceride storage, and by attenuating weight loss-induced bone loss by decreasing bone resorption and increasing osteoblast activity
Sources: 1 Bloomberg Intelligence, BI Disease Overview: Obesity
